tiprankstipranks
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
ASX:RMD
Australian Market
Holding AU:RMD?
Track your performance easily

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Earnings Dates, Call Summary & Reports

101 Followers

Earnings Data

Report Date
Jan 30, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
0.37
Last Year’s EPS
0.3
Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Jan 24, 2019
|
% Change Since: 12.94%
|
Next Earnings Date:Oct 25, 2018
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance with significant revenue growth, profit increases, and successful product innovations, despite some concerns about inventory management and potential geopolitical risks.
Company Guidance
During the Q1 Fiscal Year 2025 earnings call, ResMed reported strong financial performance with revenue growth of 11%, driven by solid demand for their sleep health and breathing health medical devices and masks. The company's operating profit increased by 27%, with earnings per share growing by 34%. They achieved double-digit revenue growth across all product and geographic categories, including a 10% increase in device sales and an 11% increase in masks and accessories sales globally. ResMed also highlighted a 12% growth in their Residential Care Software business. Gross margins improved by 320 basis points to 59.2%, fueled by manufacturing efficiencies and improved component costs. ResMed continues to invest in R&D, with expenses accounting for 6.5% of revenue. The company is also expanding its capabilities in digital health and leveraging artificial intelligence to enhance patient outcomes, contributing to a robust financial outlook for fiscal year 2025.
Strong Revenue Growth
Revenue grew by 11%, driven by high demand for sleep health and breathing health medical devices, masks, accessories, and residential care software offerings.
Increased Operating Profit and Earnings Per Share
Operating profit increased by 27%, and earnings per share grew by 34%, reflecting improved operating leverage and cost management.
Gross Margin Expansion
Gross margin increased by 320 basis points to 59.2%, driven by manufacturing efficiencies and component cost improvements.
Successful Mask Innovation
The AirTouch N30i mask with fabric-wrapped frame is set to launch, offering improved comfort and setting a new standard for CPAP therapy.
Positive Impact of GLP-1 Medications
Patients on GLP-1 medications showed increased adherence to positive airway pressure therapy, suggesting GLP-1 use is a tailwind for business.
---

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AU:RMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 25, 20182019 (Q1)
- / 0.13
0.10622.73% (+0.02)
Jan 24, 20192019 (Q2)
- / 0.16
0.1525.26% (<+0.01)
May 02, 20192019 (Q3)
- / 0.14
0.147-3.26% (>-0.01)
Jul 25, 20192019 (Q4)
- / 0.15
0.1520.00% (0.00)
Oct 24, 20192020 (Q1)
- / 0.15
0.1314.81% (+0.02)
Jan 30, 20202020 (Q2)
- / 0.19
0.1621.00% (+0.03)
Apr 30, 20202020 (Q3)
- / 0.21
0.14344.94% (+0.06)
Aug 05, 20202020 (Q4)
- / 0.21
0.15240.00% (+0.06)
Oct 29, 20202021 (Q1)
- / 0.20
0.14936.56% (+0.05)
Jan 28, 20212021 (Q2)
- / 0.23
0.19416.53% (+0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

AU:RMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 24, 2024AU$35.54AU$37.65+5.94%
Aug 01, 2024AU$32.24AU$31.65-1.83%
Jan 24, 2024AU$26.50AU$28.18+6.34%
Oct 26, 2023AU$22.18AU$21.29-4.01%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) report earnings?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) is schdueled to report earning on Jan 30, 2025, TBA Not Confirmed.
    What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) earnings time?
    Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) earnings time is at Jan 30, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock?
          What is AU:RMD EPS forecast?
          AU:RMD EPS forecast for the fiscal quarter 2025 (Q2) is 0.37.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis